CREDIT SUISSE AG/ - EVELO BIOSCIENCES INC ownership

EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 40 filers reported holding EVELO BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of EVELO BIOSCIENCES INC
ValueSharesWeighting
Q1 2023$655,113
-88.9%
3,625,415
-1.4%
0.00%
-83.3%
Q4 2022$5,922,205
-22.8%
3,678,388
+0.2%
0.01%
-33.3%
Q3 2022$7,670,000
-1.1%
3,670,178
-0.1%
0.01%
+12.5%
Q2 2022$7,754,000
-37.8%
3,674,725
-0.1%
0.01%
-27.3%
Q1 2022$12,466,000
-42.4%
3,677,164
+3.1%
0.01%
-8.3%
Q4 2021$21,648,000
-7.1%
3,566,487
+7.7%
0.01%
-7.7%
Q3 2021$23,309,000
-45.2%
3,310,911
+7.0%
0.01%
-43.5%
Q2 2021$42,536,000
+33.0%
3,095,719
+3.6%
0.02%
+43.8%
Q1 2021$31,978,000
-2.2%
2,988,570
+10.5%
0.02%0.0%
Q4 2020$32,710,000
+147.4%
2,705,511
+7.8%
0.02%
+100.0%
Q3 2020$13,224,000
+7.6%
2,509,385
+0.0%
0.01%
-11.1%
Q2 2020$12,293,000
+118.2%
2,508,932
+67.2%
0.01%
+80.0%
Q1 2020$5,633,000
+16.3%
1,500,117
+25.8%
0.01%
+25.0%
Q4 2019$4,843,000
-31.8%
1,192,769
+2.5%
0.00%
-33.3%
Q3 2019$7,096,000
-28.3%
1,163,309
+5.5%
0.01%
-33.3%
Q2 2019$9,898,000
+12.1%
1,102,273
-0.1%
0.01%
+12.5%
Q1 2019$8,830,000
-38.4%
1,103,763
+0.1%
0.01%
-46.7%
Q4 2018$14,346,000
+32.6%
1,102,676
+24.1%
0.02%
+50.0%
Q3 2018$10,819,000
+108.3%
888,287
+101.8%
0.01%
+100.0%
Q2 2018$5,194,000440,1690.01%
Other shareholders
EVELO BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Mayo Clinic 479,242$6,585,0007.28%
Flagship Pioneering Inc. 23,030,069$316,433,0004.04%
HARBOURVEST PARTNERS LLC 3,063,505$42,093,0004.02%
Trustees of Columbia University in the City of New York 113,850$1,564,0002.31%
Alphabet Inc. 1,060,495$14,571,0000.30%
Artal Group S.A. 1,000,000$13,740,0000.28%
Larson Financial Group LLC 31,354$431,0000.10%
Virtus ETF Advisers LLC 13,690$188,0000.08%
STATE OF MICHIGAN RETIREMENT SYSTEM 900,000$12,366,0000.07%
CREDIT SUISSE AG/ 3,095,719$42,536,0000.02%
View complete list of EVELO BIOSCIENCES INC shareholders